A NON-INTERVENTIONAL CHART REVIEW STUDY OF INFLIXIMAB PRECISION-GUIDED DOSING TOOL'S CLINICAL EXPERIENCE PROGRAM: INTERIM ANALYSIS OF REAL-WORLD HEALTH OUTCOMES AND EXTRAPOLATED COST SAVINGS

被引：0
|
作者：
Shim, A. [1 ]
St Jacque, S. [1 ]
Young, K. [1 ]
Ma, M. [1 ]
Aragon-Han, P. [1 ]
机构：
[1] Prometheus Labs, San Diego, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO48
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 13 条
  • [1] FIRST INTERIM ANALYSIS OF PATIENT-REPORTED OUTCOMES IN VIEW STUDY: A MULTICENTER, SINGLEARM, PROSPECTIVE, NON-INTERVENTIONAL STUDY OF VONOPRAZAN IN REAL-WORLD CLINICAL PRACTICE IN CHINA
    Xiao, Y.
    Wang, Q.
    Li, G.
    Nail, A.
    Song, Q.
    Xie, L.
    Chen, M.
    VALUE IN HEALTH, 2023, 26 (12) : S448 - S449
  • [2] Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review
    Bang, Soo-Mee
    Kang, Ka-Won
    Song, Ik-Chan
    Llamas, Cynthia
    Duan, Yinghui
    Jeong, Ji-Young
    Lee, Je-Hwan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (44)
  • [3] Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)
    Fu, Chengcheng
    Zhou, Xin
    Zhuang, Junling
    Zhou, Fan
    Li, Yuhua
    Chen, Wenming
    Fu, Rong
    Fang, Baijun
    Niu, Ting
    Zhang, Hao
    Li, Lin
    Wu, Depei
    BLOOD, 2022, 140 : 12642 - 12644
  • [4] First Interim Analysis of Safety and Effectiveness on Elderly Patients in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study on Vonoprazan in the Real-World Clinical Practice in China
    Xiao, Yinglian
    Xu, Hongwei
    Yang, Li
    Nail, Amy
    Song, Qi
    Xie, Li
    Chen, Minhu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S435 - S436
  • [5] Subgroup Analysis On Outcomes Of Adjunctive Brivaracetam In Levetiracetam-Experienced And Levetiracetam-Naive Patients In A Real-World Setting: Second Interim Analysis Of The Non-Interventional, Observational, Multinational Base Study
    Steinhoff, B. J.
    De Backer, M.
    Hellot, S.
    Leunikava, I.
    Leach, J. P.
    EPILEPSIA, 2019, 60 : 65 - 66
  • [6] The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study
    Moots, Robert J.
    Xavier, Ricardo M.
    Mok, Chi Chiu
    Rahman, Mahboob U.
    Tsai, Wen-Chan
    Al-Maini, Mustafa H.
    Pavelka, Karel
    Mahgoub, Ehab
    Kotak, Sameer
    Korth-Bradley, Joan
    Pedersen, Ron
    Mele, Linda
    Shen, Qi
    Vlahos, Bonnie
    PLOS ONE, 2017, 12 (04):
  • [7] RETRACTED: An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab (Retracted Article)
    Bokemeyer, B.
    Hlavaty, T.
    Allez, M.
    Selema, P.
    Moosavi, S.
    Cadatal, M. J.
    Fowler, H.
    Cheung, R.
    Lukas, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S410 - S410
  • [8] RETRACTION: An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab (Retraction of Vol 13, Pg S 410, 2019)
    Bokemeyer, B.
    Hlavaty, T.
    Allez, M.
    Selema, P.
    Moosavi, S.
    Cadatal, M. J.
    Fowler, H.
    Cheung, R.
    Lukas, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (03): : 428 - 428
  • [9] CARINA interim analysis: A non-interventional study of real-world treatment sequencing and outcomes in patients with advanced renal cell carcinoma initiated on first-line checkpoint inhibitor-based combination therapy.
    Nathan, Paul D.
    Allison, Jennifer
    Charnley, Natalie
    Michael, Agnieszka
    Moore, Kathryn
    Sharma, Anand
    Klair, Bhupinder
    Perrot, Valerie
    Larkin, James
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [10] Effectiveness and Safety of Apremilast in Biologic-Naive versus Biologic-Experienced Patients with Psoriatic Arthritis in Real-World Clinical Practice Settings in Germany: Interim Analysis of an Ongoing, Multicenter, Prospective, Non-interventional Study
    Wollenhaupt, Jurgen
    Bach, Christian
    Roemmler-Zehrer, Josefine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12